Zai Lab to Announce Second Quarter 2022 Financial Results on August 9, 2022

Rhea-AI Summary

Zai Lab Limited (NASDAQ: ZLAB) will announce its financial results for Q2 2022 on August 9, after U.S. market close. The company will hold a conference call and webcast on August 10 at 8:00 a.m. ET to discuss these results and provide corporate updates. Interested participants must register in advance for the call. Zai Lab focuses on innovative biopharmaceutical solutions for oncology, autoimmune disorders, infectious diseases, and neurological conditions, aiming to improve global health.

Positive

• Company is set to report Q2 2022 financial results, indicating ongoing business activity.
• Focus on transformative medicines highlights potential for future growth.

Negative

• None.

Company to Host Conference Call and Webcast on August 10, 2022, at 8:00 a.m. ET

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., July 19, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that it will report financial results and corporate updates for the three months ended June 30, 2022, after the closing of the U.S. equity markets on August 9, 2022. The Company will host a live conference call and webcast on August 10, 2022, at 8:00 a.m. ET.

Conference Call and Webcast Information

Listeners may access the live webcast by visiting the Company's website at http://ir.zailaboratory.com. Participants must register in advance of the conference call. Details are as follows:

Registration Link: https://register.vevent.com/register/BI462e47de1af64af599432ab5c90a148b

All participants must use the link provided above to complete the online registration process in advance of the conference call. Upon registering, each participant will receive a dial-in number, Direct Event passcode, and a unique access PIN, which can be used to join the conference call.

A replay will be available shortly after the call and can be accessed by visiting the Company's website at http://ir.zailaboratory.com.

About Zai Lab

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States focused on bringing transformative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders to patients in China and around the world. Our goal is to leverage our competencies and resources to positively impact human health worldwide.

For additional information about Zai Lab, including our products, business activities and partnerships, research, and other events or developments, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

Investor Relations: Lina Zhang
+86 136 8257 6943
lina.zhang@zailaboratory.com

Media: Danielle Halstrom / Xiaoyu Chen
+1 (215) 280-3898 / +86 185 0015 5011
danielle.halstrom@zailaboratory.com / xiaoyu.chen@zailaboratory.com

Source: Zai Lab Limited

FAQ

When will Zai Lab report its Q2 2022 financial results?

Zai Lab will report its Q2 2022 financial results on August 9, 2022, after the U.S. market closes.

What is the date and time of Zai Lab's conference call?

The conference call will take place on August 10, 2022, at 8:00 a.m. ET.

How can I access Zai Lab's conference call?

Participants can register for the conference call via Zai Lab's investor relations website.

What areas does Zai Lab focus on?

Zai Lab focuses on oncology, autoimmune disorders, infectious diseases, and neurological disorders.